NASDAQ:NVUS - Novus Therapeutics Price Target & Analyst Ratings

$1.05
-0.02 (-1.87 %)
(As of 06/24/2019 06:00 AM ET)
Today's Range
$1.04
Now: $1.05
$1.10
50-Day Range
$1.05
MA: $1.83
$2.73
52-Week Range
$1.01
Now: $1.05
$7.86
Volume161,057 shs
Average Volume412,333 shs
Market Capitalization$13.63 million
P/E RatioN/A
Dividend YieldN/A
Beta3.41

Analyst Ratings

Novus Therapeutics (NASDAQ:NVUS) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
1 Wall Street analysts have issued ratings and price targets for Novus Therapeutics in the last 12 months. Their average twelve-month price target is $10.00, suggesting that the stock has a possible upside of 852.38%. The high price target for NVUS is $10.00 and the low price target for NVUS is $10.00. There are currently 1 buy rating for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $10.00$10.00$12.00$9.50
Price Target Upside: 852.38% upside350.45% upside177.14% upside119.40% upside

Novus Therapeutics (NASDAQ:NVUS) Consensus Price Target History

Price Target History for Novus Therapeutics (NASDAQ:NVUS)

Novus Therapeutics (NASDAQ:NVUS) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/15/2019LADENBURG THALM/SH SHReiterated RatingBuy$10.00LowView Rating Details
2/13/2018Ascendiant Capital MarketsInitiated CoverageBuy ➝ Buy$7.00HighView Rating Details
(Data available from 6/24/2017 forward)
This page was last updated on 6/24/2019 by MarketBeat.com Staff

Featured Article: Compound Interest

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel